I agree that this site is using cookies. You can find further informations here.
X
Rigaudeau, Sophie
78  results:
Search for persons X
?
1

Isatuximab, lenalidomide, dexamethasone and bortezomib in t..:

Leleu, Xavier ; Hulin, Cyrille ; Lambert, Jerome...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

The EMMY longitudinal, cohort study: real-world data to des..:

Decaux, Olivier ; Garlantézec, Ronan ; Belhadj-Merzoug, Karim...
Clinical Hematology International.  6 (2024)  3 - p. , 2024
Link: https://doi.org/10.46989..
 
?
3

Clinical characteristics and outcome of 318 families with f..:

Dumontet, Charles ; Demangel, Delphine ; Galia, Perrine...
boreal:270175.  , 2023
Link: http://hdl.handle.net/20..
 
?
4

Clinical characteristics and outcome of 318 families with f..:

Dumontet, Charles ; Demangel, Delphine ; Galia, Perrine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107808/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Clinical characteristics and outcome of 318 families with f..:

Dumontet, Charles ; Demangel, Delphine ; Galia, Perrine...
https://discovery.ucl.ac.uk/id/eprint/10169407/1/Clinical%20characteristics%20and%20outcome%20of%20318%20families%20with%20familial%20monoclonal%20gammopathy%20A%20multicenter%20Intergroupe%20Francopho.pdf.  , 2023
Link: https://discovery.ucl.ac..
 
?
6

Clinical characteristics and outcome of 318 families with f..:

Dumontet, Charles ; Demangel, Delphine ; Galia, Perrine...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ajh.26785.  , 2023
Link: https://hal.science/hal-..
 
?
7

Clinical characteristics and outcome of 318 families with f..:

Dumontet, Charles ; Demangel, Delphine ; Galia, Perrine...
boreal:270175.  , 2023
Link: http://hdl.handle.net/20..
 
?
8

Myélome multiple à IgD mimant un myélome à chaines légères ..:

Lasri, Najat ; Lahlimi, Fatimazahra ; Tazi, Mohammed Ilias.
Pan African Medical Journal.  41 (2022)  - p. , 2022
Link: https://doi.org/10.11604..
 
?
9

Switching to daratumumab SC from IV is safe and preferred b..:

Mateos, Maria-Victoria ; Rigaudeau, Sophie ; Basu, Supratik...
Journal of Oncology Pharmacy Practice.  29 (2022)  5 - p. 1172-1177 , 2022
Link: https://doi.org/10.1177/..
 
?
10

Characteristics of SARS-CoV-2 infection in lymphoma/chronic..:

Kohn, Milena ; Alsuliman, Tamim ; Lamure, Sylvain...
info:eu-repo/semantics/altIdentifier/doi/10.1080/10428194.2022.2086249.  , 2022
Link: https://hal.science/hal-..
 
?
11

Characteristics of SARS-CoV-2 infection in lymphoma/chronic..:

Kohn, Milena ; Alsuliman, Tamim ; Lamure, Sylvain...
info:eu-repo/semantics/altIdentifier/doi/10.1080/10428194.2022.2086249.  , 2022
Link: https://hal.science/hal-..
 
?
12

Bortezomib and high-dose melphalan conditioning regimen in ..:

Roussel, Murielle ; Lauwers-Cances, Valérie ; Macro, Margaret...
boreal:260662.  , 2022
Link: http://hdl.handle.net/20..
 
?
13

Bortezomib and high-dose melphalan conditioning regimen in ..:

Roussel, Murielle ; Lauwers-Cances, Valérie ; Macro, Margaret...
boreal:260662.  , 2022
Link: http://hdl.handle.net/20..
 
?
14

Bortezomib and high-dose melphalan conditioning regimen in ..:

Roussel, Murielle ; Lauwers-Cances, Valérie ; Macro, Margaret...
urn:issn:0006-4971.  , 2022
Link: https://orbi.uliege.be/h..
 
?
15

A third anti-SARS-CoV-2 mRNA dose does not overcome the pej..:

Kohn, Milena ; Delord, Marc ; Chbat, Maureen...
Haematologica.  107 (2021)  6 - p. 1454-1459 , 2021
Link: https://doi.org/10.3324/..
 
1-15